Product Program year 2024 Source: CMS Open Payments

iDose

Device Glaucoma

Open in the dashboard

General payments

$1,404,659

4,091 payments

Research payments

$0

0 payments

Through program year 2024, $1,404,659 in general payments and $0 in research payments were reported against iDose (Glaucoma).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2024 General $1,404,659 4,091

Breakdown

Who paid General payments · program year 2024
  1. Glaukos Corporation $1,404,659 4,091 payments
Top recipients General payments · program year 2024
  1. Oluwatosin Smith Ophthalmology · Dallas, TX $155,207 11% · 10 payments
  2. Savak Teymoorian Ophthalmology · Laguna Hills, CA $101,502 7% · 46 payments
  3. Wiley Chambers Ophthalmology · Washington, DC $57,600 4% · 6 payments
  4. Inder Singh Ophthalmology · Racine, WI $46,472 3% · 22 payments
  5. Christy Benson Ophthalmology · Des Moines, IA $42,128 3% · 6 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Ophthalmology $1,071,927 78% · 1,439 practitioners
  2. Glaucoma Specialist Ophthalmology $176,746 13% · 100 practitioners
  3. Optometrist $61,720 4% · 617 practitioners
  4. Retina Specialist Ophthalmology $29,551 2% · 22 practitioners
  5. Cornea and External Diseases Specialist Ophthalmology $21,223 2% · 27 practitioners

The top 5 of 52 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. Texas $264,012 19% · 210 recipients
  2. California $255,850 18% · 245 recipients
  3. Florida $138,859 10% · 238 recipients
  4. New Jersey $68,162 5% · 103 recipients
  5. District of Columbia $58,151 4% · 8 recipients

The top 5 of 47 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

4,091 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record